Lam Research Corporation vs Procter & Gamble Co — how do they compare? Lam Research Corporation trades at $322.4 (market cap $383.63B), while Procter & Gamble Co trades at $147.55 (market cap $347.26B). The key difference: Lam Research Corporation and Procter & Gamble Co are close in size by market cap, and Procter & Gamble Co pays the higher dividend (2.92%). Which is the better fit depends on your goals.
| LRCX | PG | |
|---|---|---|
Market Cap | $383.63B | $347.26B |
Sector | Technology | Consumer Staples |
52-Week High | $433.33 | $167.18 |
52-Week Low | $94.84 | $138.10 |
Enterprise Value | $382.61B | $372.74B |
Dividend Yield | 0.34% | 2.92% |
Volume | — | 6,423,436 |
Signals from Pluang's Aura AI — not financial advice
Lam Research (LRCX) trades at $306.96, down 2.02% amid semiconductor sector weakness. The stock shows strong fundamentals with Q1 2026 EPS beating estimates at $1.47 versus $1.36 expected, continuing a pattern of earnings outperformance. Valuation metrics remain elevated with P/E at 59.22 and P/S at 18.3, reflecting premium pricing for AI-driven growth prospects. Technical indicators show bearish momentum with price testing key support at $306.
Outlook remains positive based on analyst consensus with $393 price target (78% buy ratings), though near-term risks include semiconductor cycle volatility and rich valuations. The company's positioning in AI chip manufacturing equipment and strong cash flow generation ($6.17B operating cash flow in 2025) supports long-term growth potential despite sector headwinds.
Procter & Gamble (PG) trades at $147.445, down 1.68% on the day, with a bullish technical outlook supported by moving averages and a neutral RSI near 54.62. The company reported consistent earnings beats in recent quarters, with Q1 2026 EPS of $1.59 exceeding expectations. Revenue for 2025 reached $84.28B, with a net income margin of 19.16%, while valuation metrics show a P/E of 21.8 and P/S of 4.18. Recent news highlights include a partnership with the WNBA and dividend payments of $1.09 per share.
The outlook for PG is positive, driven by strong profitability, reliable dividends, and analyst consensus favoring a buy rating with a $161.71 price target. Risks include premium valuation concerns and soft demand pressures, but the company's supply chain improvements and brand strength provide resilience. Institutional activity shows mixed positioning, with some firms increasing stakes amid overall bullish sentiment.
Trailing returns across standard periods
Latest headlines on both assets
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →